Fig. 5.
Changes in RSNA, MAP, and HR in response to changes in MAP in Wistar rats treated with ICV infusion of aCSF or Na+-rich aCSF [(Na)aCSF] with ICV infusion of FAD286 at 100 μg·kg−1·day−1 or without FAD286 (Veh) for 2 wk. Values are means ± SE (n = 7 or 8/group) analyzed as a logistic model. *P < 0.05 vs. others. aP < 0.05 vs. aCSF with or without ICV FAD286.
